Hilger, R A <br/><br/>
Correlation of ERK-phosphorylation and toxicities in patients treated with the Raf kinase inhibitor BAY 43-9006.  [electronic resource] 

 -  International journal of clinical pharmacology and therapeutics  Nov 2004 
 - 648-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0946-1965 
<br/><br/><label>Standard No.: </label>10.5414/cpp42648  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Area Under Curve<br/>Benzenesulfonates--administration & dosage<br/>Diarrhea--chemically induced<br/>Drug Administration Schedule<br/>Exanthema--chemically induced<br/>Humans<br/>Neoplasms--drug therapy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Phosphorylation--drug effects<br/>Proto-Oncogene Proteins c-raf--antagonists & inhibitors<br/>Pyridines--administration & dosage<br/>Sorafenib